Genpact Limited
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B | $3.71B | $3.52B | $3.00B |
| Cost of Revenue | $3.25B | $3.08B | $2.91B | $2.83B | $2.59B | $2.42B | $2.29B | $1.92B |
| Gross Profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B | $1.29B | $1.23B | $1.08B |
| Gross Margin | 36.0% | 35.5% | 35.1% | 35.1% | 35.6% | 34.8% | 34.8% | 36.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.05B | $967.1M | $913.1M | $938.4M | $865.7M | $789.8M | $794.9M | $693.9M |
| Operating Income | $750.2M | $702.1M | $630.9M | $502.2M | $509.0M | $438.7M | $429.4M | $348.2M |
| Operating Margin | 14.8% | 14.7% | 14.1% | 11.5% | 12.7% | 11.8% | 12.2% | 11.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $730.1M | $676.8M | $602.2M | $465.2M | $483.1M | $400.5M | $399.4M | $362.0M |
| Income Tax Expense | $177.7M | $163.2M | $-29.0M | $111.8M | $113.7M | $92.2M | $94.5M | $80.8M |
| Net Income | $552.5M | $513.7M | $631.3M | $353.4M | $369.4M | $308.3M | $304.9M | $282.0M |
| Net Margin | 10.9% | 10.8% | 14.1% | 8.1% | 9.2% | 8.3% | 8.7% | 9.4% |
| EPS (Basic) | $3.18 | $2.88 | $3.46 | $1.92 | $1.97 | $1.62 | $1.60 | $1.48 |
| EPS (Diluted) | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 | $1.57 | $1.56 | $1.45 |
| Shares Outstanding (Basic) | 173.9M | 178.4M | 182.3M | 184.2M | 187.8M | 190.4M | 190.1M | 190.7M |
| Shares Outstanding (Diluted) | 176.6M | 180.4M | 185.1M | 188.1M | 193.0M | 195.8M | 195.2M | 194.0M |
| Dividends Per Share | $0.68 | $0.61 | $0.55 | $0.50 | $0.43 | $0.39 | $0.09 | $0.30 |